Clinical Trial

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Study acronym: PLACARD
Recruiting
View on ClinicalTrials.gov →
Summary
The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-26; most recent amendment 2024-09-10.
Trial Details
NCT Number NCT06336239
Lead Sponsor Beijing Anzhen Hospital
Conditions Cardiovascular Disease, Type 2 Diabetes Mellitus
Enrollment 3,000 participants
Start Date 2023-12-21
Primary Completion 2024-07-09 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19